<PAGE>2
                           UNITED STATES
                SECURITIES AND EXCHANGE COMMISSION

                       Washington, D.C. 20549

                          FORM 10-QSB

[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
      OF THE SECURITIES AND EXCHANGE ACT OF 1934
      For the Quarter ended December 31, 2000

[ ]   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE
      EXCHANGE ACT
      For the transition period               to
                                    ----------    ----------

          Commission file number -  000-28787

                    Micro Laboratories, Inc.
         Exact name of Registrant as specified in its charter)

      NEVADA                                          05-049-4587
 (State or other   (Primary Standard Industrial    (I.R.S. Employer
jurisdictions      Classification Code Number)  Identification number)
of incorporation
or organization


29 Lakeside Drive, Johnston, Rhode Island                  02919
 (Address of principal executive offices)                (Zip Code)

                       Telephone:  (401) 949-3562
            (Registrant's telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities and Exchange
Act of 1934 during the preceding twelve months (or such shorter period that
the Registrant was required to file such reports), and (2) has been subject
to file such filing requirements for the past thirty days.

Yes    x      No
    ------       ------

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the close of the period covered by this report:

                11,338,000 Shares of Common Stock ($.001 par value)
                               (Title of Class)


Transitional Small Business Disclosure Format (check one):
    Yes           No    x
       -------       -------











<PAGE>3

                        Micro Laboratories, Inc.


PART I:        Financial Information

                     ITEM 1 - Financial statements

                     ITEM 2 - Management's' discussion and analysis of
                     financial condition and results of operations

PART II:      Other Information

                     ITEM 6 - Exhibits and Reports on Form 8-K








<PAGE>4

PART I

Item 1. Financial Statements:

Micro Laboratories, Inc.
(A Development Stage Company)
Balance Sheet
December 31, 2000 and 1999
(UNAUDITED)

Assets
<TABLE>
<CAPTION>
                                            2000                  1999
                                           -------               -------
<S>                                         <C>                    <C>
Current Assets
   Cash                                  $       0               $  18,564
   Inventory                                27,040                   4,375
   Prepaid expenses                         20,033                  21,539
   Loans and exchanges                      27,664                   3,215
                                         ---------               ---------
          Total Current Assets              74,737                  47,693

Property and Equipment
   Machinery and equipment                  47,070                  51,774
   Computer software                        11,723                 140,755
   Furniture and fixtures                    3,664                   3,664
   Leasehold improvements                    2,357                   2,357
                                         ---------                --------
                                            64,814                 198,550
   Less accumulated depreciation           (17,791)                (14,070)
                                         ---------                --------
    Net Property and Equipment              47,023                 184,480

Other Assets
   Deposits                                    600                     600
   Formulas and trademarks
     (net of accum. amort.)                 60,600                  75,921
                                          --------                --------
            Total Other Assets              61,200                  76,521
                                          --------                --------

            Total Assets                  $182,960                $308,694
                                          ========                ========

                      LIABILITIES AND EQUITY

Current Liabilities
   Accounts payable-trade                 $265,197               $  50,134
                                           187,192                  40,300
                                          --------               ---------
             Total Current Liabilities     452,389                  90,434

Stockholders Equity
   Common stock                             11,338                   5,553
   Additional paid-in-capital            1,531,345               1,170,600
   Accumulated deficit                  (1,812,112)               (957,893)
                                         ---------               ---------
             Total Stockholders Equity    (269,429)                218,260
                                         ---------               ---------

             Total Liabilities & Equity   $182,960                $308,694
                                         =========                ========
</TABLE>



<PAGE>5

Micro Laboratories, Inc.
(A Development Stage Company)
Statement of Income
For the Nine Months Ended
December 31,

 (UNAUDITED)
<TABLE>
<CAPTION>
                                              2000                 1999
<S>                                            <C>                   <C>
Revenue
   Sales                                     $        0           $   554

Operating Expenses
   Purchases                                          0             13,213
   Freight                                            0                423
   Advertising                                        0             26,886
   Depreciation expense                           1,559                  0
   Insurance expense                              1,264                  0
   Amortization expense                               0                  0
   Auto                                           4,505              3,389
   Bank service charge                                0                870
   Bookkeeping service                            2,000              7,490
   Consulting                                       450             74,369
   Education and training                             0                 73
   Legal and accounting                          40,836             21,948
   Fullfilment expenses                               0             55,000
   Office expense                                 3,481              4,108
   Dues and subscriptions                            77              1,035
   Postage                                          344                595
   Printing                                       3,135                119
   Professional fees                                900              7,865
   Rent                                             780             23,550
   Meals and Entertainment                            0              1,026
   Repairs and maintenance                            0              2,033
   Research and development expense                   0            100,595
   Office supplies                                  125                  0
   Service expense                                  500                250
   Telephone                                      4,510             13,546
   Travel                                         2,456              1,727
   Utilities                                        403                933
   Miscellaneous                                     30                  0
   Payroll and payroll taxes                          0                  0
   Licenses                                         200                200
                                                 ------             ------
             Total Operating Expenses            67,555            361,243
                                                -------           --------

Loss from Operations                            (67,555)          (360,689)

Other Income
   Gain on sale of assets                             0              9,825
   Interest income                                    0              1,681
                                                -------            -------
             Total Other Income                       0             11,506
                                                -------            -------

             Loss before Income Taxes           (67,555)          (349,183)
                                                -------            -------

Provision for Income Taxes
   Provision for state income taxes                   0                  0
                                                -------            -------
         Total Provision for Income Taxes             0                  0

Net Loss                                       $(67,555)         $(349,183)
</TABLE>




<PAGE>6

Micro Laboratories, Inc.
(A Development Stage Company)
Statement of Cash Flows
For the Nine Months Ended
December 31,

 (UNAUDITED)
<TABLE>
<CAPTION>
                                                 2000                 1999
<S>                                               <C>                 <C>
Cash flows from operating activities:
   Net loss                                   $(67,555)            $(349,183)
   Adjustments to reconcile net income to
      net cash used for operating activities:
      Depreciation and amortization              1,559                     0
   (Increase) decrease in assets:
      Inventory                                      0                 7,779
      Deposits                                       0                     0
      Prepaid Expenses                               0                 5,797
    Increase (decrease) in liabilities:
      Accounts payable                           3,635                 4,388
      Notes payable                             62,361                (4,700)
                                              --------              --------
           Net cash used by
              operating activities              67,555              (355,919)

Investing activities:
   Acquisition of intangible assets                  0               (30,127)
   Gain on sale of asset                             0                     0
   Acquisition of property and equipment (net)       0               (29,763)
   Shareholder loans                                 0                     0
                                              --------               -------
            Net cash used for investing activities   0               (58,415)

Net increase (decrease) in cash during the period    0              (394,334)

Cash balance, beginning of period                    0               412,899

Cash balance, end of period                     $    0             $  18,565
                                                ======             =========
</TABLE>



<PAGE>7

Note 1.    In the opinion of management of Micro Laboratories, Inc.,
the unaudited financial statements of Micro Laboratories, Inc. for the
interim period shown, include all adjustments, necessary for a fair
presentation of the financial position at December 31, 2000, and the
results of operations and cash flows for the period then ended.  The
results of operations for the interim periods shown may not be
indicative of the results that may be expected for the fiscal year.
These statements should be read in conjunction with the financial
statements and notes thereto included in the Company's Form 10-K for
the year March 31, 2000.





<PAGE>8
              Micro Laboratories, Inc.

PART I (cont.)

Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations:

Trends and Uncertainties. Demand for Micro's products will be
dependent on, among other things, general economic conditions, which
are cyclical in nature.  Inasmuch as a major portion of the
Corporation's activities is the receipt of revenues from the sale of
its products, Micro's business operations may be adversely affected by
its competitors and prolonged recessionary periods.

Micro is entering a phase of conversion from a Development Stage
Corporation to an Operational Corporation.  Agreements have been
reached to provide key personnel in the areas of marketing and sales.
An agreement has been reached with three large distributors to include
the west coast, mid west and New England.  Preliminary market research
was conducted to arrive at the flavorings for the Micro SprayT product
line.  Micro sent a representative to the National Association of
Chain Drug Stores (NACDS) trade convention in Philadelphia, PA also
the packaging show in Chicago Ill. The Corporation plans to use a
"target" marketing approach for the distribution of its Micro SprayT
product line.

Capital and Source of Liquidity. Micro currently has no material
commitments for capital expenditures.

For the nine months ended December 31, 2000, Micro did not pursue any
investing activities.

For the nine months ended December 31, 1999, Micro acquired property
and equipment (net) of $29,763 and acquired intangible assets of
$30,127.   For the nine months ended December 31, 1999, Micro had net
cash used for investing activities of $58,415.

For the nine months ended December 31, 2000 and 1999, Micro did not
pursue any financing activities.

On a long term basis, liquidity is dependent on commencement of
operations as discussed above, receipt of revenues, additional
infusions of capital and debt financing.  Micro believes that
additional capital and debt financing in the short term will allow
Micro to increase its marketing and sales efforts and become a fully
operational Corporation thereafter resulting in increased revenue and
greater liquidity in the long term.  However, there can be no
assurance that Micro will be able to obtain additional equity or debt
financing in the future, if at all.

Results of Operations.
Micro is accurately classified as a "development stage Corporation"
and as such has conducted startup and development operations that
include:
   completed photo shoots, created Corporation logos, brochures, sales
literature, product labels and packaging design, UPCs
   prepared the product line of six items for distribution roll out
   completed negotiations with three large distributors to include
west coast, mid west, and New England to represent and sell the
companies product lines to national chains.

Micro has not received any material revenues since inception.

For the nine months ended December 31, 2000, Micro had a net loss of
$67,555.   Operating expenses for the nine months ended December 31,
2000 were $67,555 and consisted of depreciation of $1,559, insurance
of $1,264 ,auto expense of $4,505, bookkeeping service of $2,000,
consulting of $450, office expense of $3,481, legal and accounting of
$40,836, postage of $344 , printing expense of $3,135, rent of $780,
service expense of $500, telephone of $4,510, travel of $2,456,
utilities of $403, licenses of $200  and miscellaneous of $1,132.

For the nine months ended December 31, 1999, Micro had a net loss of
$306,689.   Operating expenses for the nine months ended December 31,
1999 were $361,243 and consisted of purchases of $13,213, freight of
$423, advertising of $26,886, auto expense of $3,389, bank service
charge of $870, bookkeeping service of $7,490, consulting of $74,369,
education and training of $73, legal and accounting expenses of
$21,948, office expense of $4,108, dues and subscriptions of $1,035,
postage of $595, printing of $119, professional fees of $7,865, rent
of $23,550, meals and entertainment of $1,026, repairs and maintenance
of $2,033, research and development expenses of $100,595, service
expense of $250, telephone of $13,546,utilities of $933, and licenses
of $200, fullfilment expenses of $55,000 and miscellaneous expenses of
$1,727.

Plan of Operation. Micro is in the development stage and has not
conducted any significant operations to date or received any material
operating revenues.  Micro may experience problems; delays, expenses
and difficulties sometimes encountered by an enterprise in Micro's
stage of development, many of which are beyond Micro's control.  These
include, but are not limited to, unanticipated problems relating to
additional costs and expenses that may exceed current estimates and
competition.

Micro is not delinquent in any of its obligations even though Micro
has generated limited operating revenues.  The Corporation intends to
market its products and services utilizing cash made available from
the private sale of its securities and operations. Micro's management
is of the opinion that the proceeds of the sales of its securities and
future revenues will be sufficient to pay its expenses for the next
twelve months.



<PAGE>10

MICRO LABORATORIES, INC.

PART II


Item 6. Exhibits and Reports on Form 8-K

(a)   Exhibits (numbered in accordance with Item 601 of
      Regulation S-K)

      None

(b)   Reports on Form 8-K

None




                           SIGNATURE

Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly
authorized.


                                      /s/ Robert Thistle
                                 ----------------------------
                                     Robert Thistle, President


February 19, 2001